484 related articles for article (PubMed ID: 9345482)
1. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
2. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
[TBL] [Abstract][Full Text] [Related]
3. Inter-modality comparisons of seizure focus lateralization in complex partial seizures.
Meyer PT; Cortés-Blanco A; Pourdehnad M; Levy-Reis I; Desiderio L; Jang S; Alavi A
Eur J Nucl Med; 2001 Oct; 28(10):1529-40. PubMed ID: 11685497
[TBL] [Abstract][Full Text] [Related]
4. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome.
Carne RP; O'Brien TJ; Kilpatrick CJ; MacGregor LR; Hicks RJ; Murphy MA; Bowden SC; Kaye AH; Cook MJ
Brain; 2004 Oct; 127(Pt 10):2276-85. PubMed ID: 15282217
[TBL] [Abstract][Full Text] [Related]
5. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
Koepp MJ; Labbé C; Richardson MP; Brooks DJ; Van Paesschen W; Cunningham VJ; Duncan JS
Brain; 1997 Oct; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
[TBL] [Abstract][Full Text] [Related]
7. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
[TBL] [Abstract][Full Text] [Related]
8. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Koepp MJ; Hammers A; Labbé C; Woermann FG; Brooks DJ; Duncan JS
Neurology; 2000 Jan; 54(2):332-9. PubMed ID: 10668692
[TBL] [Abstract][Full Text] [Related]
9. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
Muzik O; da Silva EA; Juhasz C; Chugani DC; Shah J; Nagy F; Canady A; von Stockhausen HM; Herholz K; Gates J; Frost M; Ritter F; Watson C; Chugani HT
Neurology; 2000 Jan; 54(1):171-9. PubMed ID: 10636144
[TBL] [Abstract][Full Text] [Related]
10. The added value of [18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery.
Uijl SG; Leijten FS; Arends JB; Parra J; van Huffelen AC; Moons KG
Epilepsia; 2007 Nov; 48(11):2121-9. PubMed ID: 17651417
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.
Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F
Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767
[TBL] [Abstract][Full Text] [Related]
12. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry.
Szelies B; Weber-Luxenburger G; Mielke R; Pawlik G; Kessler J; Pietrzyk U; Bauer B; Heiss WD
Eur J Neurol; 2000 Jul; 7(4):393-400. PubMed ID: 10971598
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
[TBL] [Abstract][Full Text] [Related]
14. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
[TBL] [Abstract][Full Text] [Related]
15. Surgery in temporal lobe epilepsy patients without cranial MRI lateralization.
Gomceli YB; Erdem A; Bilir E; Kutlu G; Kurt S; Erden E; Karatas A; Erbas C; Serdaroglu A
Acta Neurol Belg; 2006 Mar; 106(1):9-14. PubMed ID: 16776430
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in presurgical localization of epileptic foci.
Csaba J
Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of focus laterality in temporal lobe epilepsy: a quantitative study comparing double inversion-recovery MR imaging at 3T with FDG-PET.
Morimoto E; Okada T; Kanagaki M; Yamamoto A; Fushimi Y; Matsumoto R; Takaya S; Ikeda A; Kunieda T; Kikuchi T; Paul D; Miyamoto S; Takahashi R; Togashi K
Epilepsia; 2013 Dec; 54(12):2174-83. PubMed ID: 24117006
[TBL] [Abstract][Full Text] [Related]
18. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
Koepp MJ; Richardson MP; Labbé C; Brooks DJ; Cunningham VJ; Ashburner J; Van Paesschen W; Revesz T; Duncan JS
Neurology; 1997 Sep; 49(3):764-73. PubMed ID: 9305338
[TBL] [Abstract][Full Text] [Related]
19. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT
Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004
[TBL] [Abstract][Full Text] [Related]
20. 18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.
Liew CJ; Lim YM; Bonwetsch R; Shamim S; Sato S; Reeves-Tyer P; Herscovitch P; Dustin I; Bagic A; Giovacchini G; Theodore WH
Epilepsia; 2009 Feb; 50(2):234-9. PubMed ID: 18801033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
